BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Stock Fundamental Analysis
FRA:BRYN - Deutsche Boerse Ag - US0846707026 - Common Stock - Currency: EUR
We assign a fundamental rating of 4 out of 10 to BRYN. BRYN was compared to 51 industry peers in the Financial Services industry. Both the profitability and the financial health of BRYN get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on BRYN.
1. Profitability
1.1 Basic Checks
BRYN had positive earnings in the past year.
In the past year BRYN had a positive cash flow from operations.
BRYN had positive earnings in 4 of the past 5 years.
BRYN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
BRYN has a Return On Assets of 6.95%. This is in the better half of the industry: BRYN outperforms 74.51% of its industry peers.
Looking at the Return On Equity, with a value of 12.36%, BRYN is in line with its industry, outperforming 54.90% of the companies in the same industry.
BRYN's Return On Invested Capital of 4.50% is in line compared to the rest of the industry. BRYN outperforms 50.98% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BRYN is significantly below the industry average of 11.50%.
The 3 year average ROIC (4.13%) for BRYN is below the current ROIC(4.50%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.95% | ||
| ROE | 12.36% | ||
| ROIC | 4.5% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
1.3 Margins
With a decent Profit Margin value of 21.79%, BRYN is doing good in the industry, outperforming 70.59% of the companies in the same industry.
In the last couple of years the Profit Margin of BRYN has declined.
BRYN's Operating Margin of 15.89% is in line compared to the rest of the industry. BRYN outperforms 52.94% of its industry peers.
BRYN's Operating Margin has improved in the last couple of years.
The Gross Margin of BRYN (16.43%) is worse than 62.75% of its industry peers.
In the last couple of years the Gross Margin of BRYN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.89% | ||
| PM (TTM) | 21.79% | ||
| GM | 16.43% |
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BRYN is still creating some value.
BRYN has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, BRYN has less shares outstanding
The debt/assets ratio for BRYN has been reduced compared to a year ago.
2.2 Solvency
BRYN has an Altman-Z score of 1.34. This is a bad value and indicates that BRYN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BRYN (1.34) is comparable to the rest of the industry.
BRYN has a debt to FCF ratio of 10.44. This is a negative value and a sign of low solvency as BRYN would need 10.44 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.44, BRYN is in line with its industry, outperforming 45.10% of the companies in the same industry.
BRYN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.19, BRYN is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 10.44 | ||
| Altman-Z | 1.34 |
ROIC/WACC1.4
WACC3.22%
2.3 Liquidity
BRYN has a Current Ratio of 1.14. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.14, BRYN perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
A Quick Ratio of 0.91 indicates that BRYN may have some problems paying its short term obligations.
The Quick ratio of BRYN (0.91) is worse than 64.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
BRYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.77%, which is quite good.
Measured over the past years, BRYN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.78% on average per year.
The Revenue has been growing slightly by 0.63% in the past year.
Measured over the past years, BRYN shows a small growth in Revenue. The Revenue has been growing by 7.84% on average per year.
EPS 1Y (TTM)13.77%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-14.02%
Revenue 1Y (TTM)0.63%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-0.16%
3.2 Future
Based on estimates for the next years, BRYN will show a small growth in Earnings Per Share. The EPS will grow by 2.26% on average per year.
The Revenue is expected to grow by 4.89% on average over the next years.
EPS Next Y-6.33%
EPS Next 2Y-0.17%
EPS Next 3Y1.54%
EPS Next 5Y2.26%
Revenue Next Year-2.46%
Revenue Next 2Y1.29%
Revenue Next 3Y-0.36%
Revenue Next 5Y4.89%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
BRYN is valuated cheaply with a Price/Earnings ratio of 0.01.
Compared to the rest of the industry, the Price/Earnings ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 98.04% of the companies listed in the same industry.
BRYN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.29.
The Price/Forward Earnings ratio is 0.01, which indicates a rather cheap valuation of BRYN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 98.04% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.74. BRYN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.01 | ||
| Fwd PE | 0.01 |
4.2 Price Multiples
BRYN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BRYN is cheaper than 98.04% of the companies in the same industry.
BRYN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BRYN is cheaper than 98.04% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 0.06 | ||
| EV/EBITDA | 1.15 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y-0.17%
EPS Next 3Y1.54%
5. Dividend
5.1 Amount
No dividends for BRYN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:BRYN (7/8/2025, 9:25:14 AM)
407.05
-1.9 (-0.46%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)
Earnings (Next)
Inst Owners33.78%
Inst Owner ChangeN/A
Ins Owners38.2%
Ins Owner ChangeN/A
Market Cap586.15M
Analysts80
Price Target460.55 (13.14%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.51%
Min EPS beat(2)-9.78%
Max EPS beat(2)42.8%
EPS beat(4)2
Avg EPS beat(4)10.96%
Min EPS beat(4)-10.41%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)11.15%
EPS beat(12)8
Avg EPS beat(12)9.18%
EPS beat(16)11
Avg EPS beat(16)8.21%
Revenue beat(2)0
Avg Revenue beat(2)-2.05%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)-0.01%
Revenue beat(4)0
Avg Revenue beat(4)-2.99%
Min Revenue beat(4)-7.69%
Max Revenue beat(4)-0.01%
Revenue beat(8)4
Avg Revenue beat(8)0.2%
Revenue beat(12)5
Avg Revenue beat(12)-0.61%
Revenue beat(16)6
Avg Revenue beat(16)-0.89%
PT rev (1m)-3.52%
PT rev (3m)-5.41%
EPS NQ rev (1m)0.42%
EPS NQ rev (3m)-2.27%
EPS NY rev (1m)-0.67%
EPS NY rev (3m)-3.44%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)-0.98%
Revenue NY rev (1m)-4.03%
Revenue NY rev (3m)-2.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.01 | ||
| Fwd PE | 0.01 | ||
| P/S | 0 | ||
| P/FCF | 0.06 | ||
| P/OCF | 0.02 | ||
| P/B | 0 | ||
| P/tB | 0 | ||
| EV/EBITDA | 1.15 |
EPS(TTM)27200.42
EY6682.33%
EPS(NY)28039.57
Fwd EY6888.48%
FCF(TTM)7143.99
FCFY1755.06%
OCF(TTM)18313.8
OCFY4499.15%
SpS219849.58
BVpS387528.78
TBVpS316801
PEG (NY)N/A
PEG (5Y)0
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.95% | ||
| ROE | 12.36% | ||
| ROCE | 5.56% | ||
| ROIC | 4.5% | ||
| ROICexc | 4.68% | ||
| ROICexgc | 5.61% | ||
| OM | 15.89% | ||
| PM (TTM) | 21.79% | ||
| GM | 16.43% | ||
| FCFM | 3.25% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexcg growth 3Y9.15%
ROICexcg growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 10.44 | ||
| Debt/EBITDA | 1.75 | ||
| Cap/Depr | 145.65% | ||
| Cap/Sales | 5.08% | ||
| Interest Coverage | 11.99 | ||
| Cash Conversion | 42.99% | ||
| Profit Quality | 14.91% | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 1.34 |
F-Score4
WACC3.22%
ROIC/WACC1.4
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.77%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-14.02%
EPS Next Y-6.33%
EPS Next 2Y-0.17%
EPS Next 3Y1.54%
EPS Next 5Y2.26%
Revenue 1Y (TTM)0.63%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-0.16%
Revenue Next Year-2.46%
Revenue Next 2Y1.29%
Revenue Next 3Y-0.36%
Revenue Next 5Y4.89%
EBIT growth 1Y12.44%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-47.83%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-21.13%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%